UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The limited application of stem cells in medicine: a review

Stem cell research & therapy, 2018-01, Vol.9 (1), p.1-1, Article 1

Poulos, Jordan

2018

Volltextzugriff (PDF)

Data gaps in electronic health record (EHR) systems: An audit of problem list completeness during the COVID-19 pandemic

International journal of medical informatics (Shannon, Ireland), 2021-06, Vol.150, p.104452-104452, Article 104452

2021

Volltextzugriff (PDF)

Systematic evaluation and external validation of 22 prognostic models among hospitalised adults with COVID-19: an observational cohort study

The European respiratory journal, 2020-12, Vol.56 (6), p.2003498

2020

Volltextzugriff (PDF)

Congenital myasthenic syndromes: a retrospective natural history study of respiratory outcomes in a single centre

Brain communications, 2023-11, Vol.5 (6), p.fcad299-fcad299

2023

Volltextzugriff (PDF)

Gulf of Mexico estuarine blue carbon stock, extent and flux: Mangroves, marshes, and seagrasses: A North American hotspot

The Science of the total environment, 2019-02, Vol.653, p.1253-1261

2019

Volltextzugriff (PDF)

Exploring lake user and manager knowledge of aquatic invasive species in New Hampshire freshwater lake systems, USA

Journal for nature conservation, 2023-06, Vol.73, p.126405, Article 126405

2023

Volltextzugriff (PDF)

Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection

The New England journal of medicine, 2017-06, Vol.376 (22), p.2134-2146

2017

Volltextzugriff (PDF)

Development of a novel shared decision making aid for primary immunodeficiency diseases

Immunotherapy, 2023-06, Vol.15 (9), p.647-656

2023

Volltextzugriff (PDF)

Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment‐naïve patients with chronic HCV genotype 1 infection (ESSENTIAL II)

Alimentary pharmacology & therapeutics, 2015-10, Vol.42 (7), p.829-844

2015

Volltextzugriff (PDF)

Mixed reality game prototypes for upper body exercise and rehabilitation

2012 IEEE Virtual Reality Workshops (VRW), 2012, p.181-182

2012

Volltextzugriff (PDF)

Minimally Invasive and Office-Based Procedures in Facial Plastic Surgery

Volltextzugriff (PDF)

Skyfarer: Design Case Study of a Mixed Reality Rehabilitation Video Game

Design, User Experience, and Usability. User Experience Design for Diverse Interaction Platforms and Environments, p.699-710

Volltextzugriff (PDF)

Structure activity studies on the C-terminal hexapeptide of substance P with modifications at the glutaminyl and methioninyl residues

Journal of medicinal chemistry, 1987-08, Vol.30 (8), p.1512-1515

1987

Volltextzugriff (PDF)

Synthesis and biological activity of substance P C-terminal hexapeptide analogues: structure-activity studies

Journal of medicinal chemistry, 1986-07, Vol.29 (7), p.1281-1284

1986

Volltextzugriff (PDF)

Synthesis of a potent agonist of substance P by modifying the methionyl and glutaminyl residues of the C-terminal hexapeptide of substance P : structure-activity relationships

International journal of peptide and protein research, 1991-10, Vol.38 (4), p.350-356

1991

Volltextzugriff (PDF)

Synthesis of potent antagonists of substance P by modifying the methionyl and glutaminyl residues of its C-terminal hexapeptide and without using d-amino acids

International Journal of Peptide and Protein Research, 1993-04, Vol.41 (4), p.411-414

1993

Volltextzugriff (PDF)

Synthesis of a potent antagonist of substance P by replacing the CH2SCH3 and the α-carboxamide groups of the methionine al [Orn6]-SP6-11 by benzyl ester groups

International Journal of Peptide and Protein Research, 1993-08, Vol.42 (6), p.565-569

1993

Volltextzugriff (PDF)

Synthesis of a potent agonist of substance P by modifying the methionyl and glutaminyl residues of the C-terminal hexapeptide of substance P

International Journal of Peptide and Protein Research, 1991-10, Vol.38 (4), p.350-356

1991

Volltextzugriff (PDF)

ChemInform Abstract: Synthesis and Biological Activity of Substance P C‐Terminal Hexapeptide Analogues: Structure‐Activity Studies

Chemischer Informationsdienst, 1986-12, Vol.17 (48)

1986

Volltextzugriff (PDF)

Synthesis of a potent antagonist of substance P by replacing the CH 2 SCH 3 and the α‐carboxamide groups of the methionine al [Orn 6 ]‐SP 6–11 by benzyl ester groups

International journal of peptide and protein research, 1993-08, Vol.42 (6), p.565-569

1993

Volltextzugriff (PDF)

Synthesis of a potent antagonist of substance P by replacing the CH2SCH3 and the α-carboxamide groups of the methionine at [Orn6]-Sp6-11 by benzyl ester groups

International journal of peptide and protein research, 1993-12, Vol.42 (6), p.565-569

1993

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(16)
Mit Volltextzugriff
(18)

Publikationsform

Sprache

Englisch
(20)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The limited application of stem cells in medicine: a review

Data gaps in electronic health record (EHR) systems: An audit of problem list completeness during the COVID-19 pandemic

Systematic evaluation and external validation of 22 prognostic models among hospitalised adults with COVID-19: an observational cohort study

Congenital myasthenic syndromes: a retrospective natural history study of respiratory outcomes in a single centre

Gulf of Mexico estuarine blue carbon stock, extent and flux: Mangroves, marshes, and seagrasses: A North American hotspot

Exploring lake user and manager knowledge of aquatic invasive species in New Hampshire freshwater lake systems, USA

Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection

Development of a novel shared decision making aid for primary immunodeficiency diseases

Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment‐naïve patients with chronic HCV genotype 1 infection (ESSENTIAL II)

Mixed reality game prototypes for upper body exercise and rehabilitation

Minimally Invasive and Office-Based Procedures in Facial Plastic Surgery

Skyfarer: Design Case Study of a Mixed Reality Rehabilitation Video Game

Structure activity studies on the C-terminal hexapeptide of substance P with modifications at the glutaminyl and methioninyl residues

Synthesis and biological activity of substance P C-terminal hexapeptide analogues: structure-activity studies

Synthesis of a potent agonist of substance P by modifying the methionyl and glutaminyl residues of the C-terminal hexapeptide of substance P : structure-activity relationships

Synthesis of potent antagonists of substance P by modifying the methionyl and glutaminyl residues of its C-terminal hexapeptide and without using d-amino acids

Synthesis of a potent antagonist of substance P by replacing the CH2SCH3 and the α-carboxamide groups of the methionine al [Orn6]-SP6-11 by benzyl ester groups

Synthesis of a potent agonist of substance P by modifying the methionyl and glutaminyl residues of the C-terminal hexapeptide of substance P

ChemInform Abstract: Synthesis and Biological Activity of Substance P C‐Terminal Hexapeptide Analogues: Structure‐Activity Studies

Synthesis of a potent antagonist of substance P by replacing the CH 2 SCH 3 and the α‐carboxamide groups of the methionine al [Orn 6 ]‐SP 6–11 by benzyl ester groups

Synthesis of a potent antagonist of substance P by replacing the CH2SCH3 and the α-carboxamide groups of the methionine at [Orn6]-Sp6-11 by benzyl ester groups

Suchergebnisse filtern